Hematology
Credibility 94
Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.
October 13, 2026 · JAMA
Key takeaway
This study found that arginine treatment did not help Black children and young adults with sickle cell pain crises heal faster or use less pain medicine. This matters for our community because it shows we need to keep looking for better treatments for these painful episodes.
Why this matters for our communities
Research in hematology helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Hematology
August 24, 2026Experiences of family building counseling and perceptions of reproductive technology among adults with sickle cell disease.Read August 20, 2026Risk of infertility among women with sickle cell disease.Read August 14, 2026Moving on Up: Shifting Sickle Cell Disease Management During Adolescence in Preparation for Adulthood.Read